7276 - 7300 of 7939 Results
Title
Year
-
OPENTitle: The Current State and Needs of North American Movement Disorders Fellowship ProgramsJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2013Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/701426Best OA location URL: https://downloads.hindawi.com/journals/pd/2013/701426.pdfCitation Count: 6
- The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini Review2013RESTRICTEDTitle: The Molecular Chaperone GRP78/BiP as a Therapeutic Target for Neurodegenerative Disorders: A Mini ReviewJournal Name: Journal of Genetic Syndromes & Gene TherapyPublisher: OMICS Publishing GroupVol: 04Issue #: 02Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4172/2157-7412.1000128Best OA location URL: https://europepmc.org/articles/pmc3674964?pdf=renderCitation Count: 80
-
RESTRICTEDTitle: The Role of Innate and Adaptive Immunity in Parkinson's DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 3Issue #: 4Start Page: 493End Page: 514Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130250Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130250?id=journal-of-parkinsons-disease%2Fjpd130250Citation Count: 262
-
RESTRICTEDTitle: The Role of Oxidative Stress in Parkinson's DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 3Issue #: 4Start Page: 461End Page: 491Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130230Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130230?id=journal-of-parkinsons-disease%2Fjpd130230Citation Count: 1321
- What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?2013RESTRICTEDTitle: What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?Journal Name: PrionPublisher: Informa UK LimitedVol: 7Issue #: 1Start Page: 92End Page: 97Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4161/pri.23806Best OA location URL: https://www.tandfonline.com/doi/pdf/10.4161/pri.23806?needAccess=trueCitation Count: 54
-
OPENTitle: α-synuclein Imaging: A Critical Need for Parkinson's Disease ResearchJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 3Issue #: 4Start Page: 565End Page: 567Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-130247Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd130247?id=journal-of-parkinsons-disease%2Fjpd130247Citation Count: 72
-
OPENTitle: α-Synuclein Levels in Blood Plasma from LRRK2 Mutation CarriersJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 12Start Page: e52312End Page: e52312Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0052312Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0052312&type=printableCitation Count: 39
-
OPENTitle: Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 110Issue #: 2Start Page: 636End Page: 641Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1220399110Best OA location URL: https://www.pnas.org/content/pnas/110/2/636.full.pdfCitation Count: 186
-
OPENTitle: Activity‐dependent secretion of alpha‐synuclein by enteric neuronsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 125Issue #: 4Start Page: 512End Page: 517Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12131Citation Count: 89
-
RESTRICTEDTitle: In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s diseaseJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 120Issue #: 4Start Page: 571End Page: 576Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00702-012-0956-yBest OA location URL: https://europepmc.org/articles/pmc3612386?pdf=renderCitation Count: 37
-
OPENTitle: Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegenerationJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 110Issue #: 1Start Page: 300End Page: 305Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1217296110Best OA location URL: https://www.pnas.org/content/pnas/110/1/300.full.pdfCitation Count: 112
- β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia2012OPENTitle: β‐amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementiaJournal Name: Movement DisordersPublisher: WileyVol: 28Issue #: 3Start Page: 296End Page: 301Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.25213Best OA location URL: https://europepmc.org/articles/pmc3680885?pdf=renderCitation Count: 82
- Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations2012OPENTitle: Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterationsJournal Name: Neurochemistry InternationalPublisher: Elsevier BVVol: 62Issue #: 2Start Page: 145End Page: 156Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuint.2012.12.001Best OA location URL: https://ri.conicet.gov.ar/bitstream/11336/18335/3/CONICET_Digital_Nro.9999s.pdfCitation Count: 48
- Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified Individuals2012RESTRICTEDTitle: Analysis of Copy Number Variation in Alzheimer’s Disease in a Cohort of Clinically Characterized and Neuropathologically Verified IndividualsJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 12Start Page: e50640End Page: e50640Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0050640Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0050640&type=printableCitation Count: 53
-
OPENTitle: Capgras syndrome in Dementia with Lewy BodiesJournal Name: International PsychogeriatricsPublisher: Elsevier BVVol: 25Issue #: 5Start Page: 843End Page: 849Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1017/s1041610212002189Best OA location URL: https://europepmc.org/articles/pmc4004517?pdf=renderCitation Count: 42
- Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on Glycolysis2012OPENTitle: Competitive HIF Prolyl Hydroxylase Inhibitors Show Protection against Oxidative Stress by a Mechanism Partially Dependent on GlycolysisJournal Name: ISRN NeurosciencePublisher: Hindawi LimitedVol: 2013Issue #:Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2013/598587Best OA location URL: https://downloads.hindawi.com/archive/2013/598587.pdfCitation Count: 5
- KIF6 719Arg Allele is Associated with Statin Effects on Cholesterol Levels in Amnestic Mild Cognitive Impairment and Alzheimer's Disease Patients2012OPENTitle: KIF6 719Arg Allele is Associated with Statin Effects on Cholesterol Levels in Amnestic Mild Cognitive Impairment and Alzheimer's Disease PatientsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 33Issue #: 1Start Page: 111End Page: 116Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2012-121015Best OA location URL: https://europepmc.org/articles/pmc3731451?pdf=renderCitation Count: 5
- Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop2012OPENTitle: Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshopJournal Name: Clinical TrialsPublisher: SAGE PublicationsVol: 9Issue #: 6Start Page: 671End Page: 680Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/1740774512461859Best OA location URL: https://europepmc.org/articles/pmc5570450?pdf=renderCitation Count: 66
- Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic Effects2012RESTRICTEDTitle: Psychiatric Drugs Bind to Classical Targets Within Early Exocytotic Pathways: Therapeutic EffectsJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 72Issue #: 11Start Page: 907End Page: 915Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2012.05.020Best OA location URL: https://europepmc.org/articles/pmc6167061?pdf=renderCitation Count: 49
- Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease2012OPENTitle: Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 11Start Page: e50040End Page: e50040Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0050040Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0050040&type=printableCitation Count: 48
- Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains2012OPENTitle: Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brainsJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 240Issue #:Start Page: 190End Page: 204Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.020Best OA location URL: https://europepmc.org/articles/pmc3720241?pdf=renderCitation Count: 131
-
OPENTitle: LRRK2 interactions with α-synuclein in Parkinson’s disease brains and in cell modelsJournal Name: Journal of Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 91Issue #: 4Start Page: 513End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00109-012-0984-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00109-012-0984-y.pdfCitation Count: 68
-
OPENTitle: Evaluation of TorsinA as a Target for Parkinson Disease Therapy in Mouse ModelsJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 7Issue #: 11Start Page: e50063End Page: e50063Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0050063Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0050063&type=printableCitation Count: 3
- Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment2012OPENTitle: Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairmentJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 240Issue #:Start Page: 44End Page: 56Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2012.11.007Best OA location URL: https://europepmc.org/articles/pmc3552027?pdf=renderCitation Count: 63
-
OPENTitle: Validation of nigrostriatal positron emission tomography measures: Critical limitsJournal Name: Annals of NeurologyPublisher: WileyVol: 73Issue #: 3Start Page: 390End Page: 396Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.23798Best OA location URL: https://europepmc.org/articles/pmc3631302?pdf=renderCitation Count: 79